IP Library Granted Patent US 8,586,008
Granted Patent B2
US 8,586,008 · App. 13/307,533 · Granted Nov 19, 2013

Pharmaceutical foam

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,586,008
App. No.
13/307,533
Granted
Nov 19, 2013
Kind
B2
Abstract

The present invention provides various pharmaceutically active topical delivery compositions. In particular, compositions of the present invention are present in a pressurized container comprising a quick-breaking alcoholic foaming agent, such that when the composition is released, i.e., dispensed, from the pressurized container, a quick-breaking temperature sensitive foam is formed. In addition, the present invention provides various aspects related to such compositions, including methods for modulating a foam characteristic, methods for improving the shelf-life of a pharmaceutically active compound, methods for the percutaneous treatment of various diseases, infections, and illnesses, and methods for evaluating foam characteristics.

Claims (38)

1. A topical delivery foam composition in a pressurized container, said composition comprising:

up to 15% w/w based on the total weight of the composition of at least one pharmaceutically active agent, wherein the at least one pharmaceutically active agent comprises a combination of benzoyl peroxide and clindamycin or a salt or ester thereof;

from about 83% to about 97.9% w/w based on the total weight of the composition of an aqueous quick-breaking foaming agent comprising water, a surfactant and a pH adjusting agent present in an amount sufficient to adjust the pH of the composition to between about 4.0 to about 6.5, wherein the aqueous quick-breaking foaming agent does not contain a C 1 -C 6 alcohol; and

from about 2% to about 7% w/w based on the total weight of the composition of an aerosol propellant selected from the group consisting of a hydrocarbon, a chlorofluorocarbon, dimethyl ether, hydrofluorocarbons and a mixture thereof,

wherein said composition is a quick-breaking foam after release from said container.

2. The topical delivery foam composition of claim 1 , wherein said clindamycin is clindamycin phosphate.

3. The topical delivery foam composition of claim 1 , wherein said surfactant is selected from the group consisting of a block co-polymer, fatty acid ethoxylates, fatty alcohol ethoxylates, polysorbates and glycerol ester ethoxylates.

4. The topical delivery foam composition of claim 3 , wherein said surfactant is a block co-polymer.

5. The topical delivery foam composition of claim 4 , wherein said block co-polymer is a poloxamer.

6. The topical delivery foam composition of claim 1 , wherein said surfactant is selected from the group consisting of polysorbate 20, polysorbate 60, polysorbate 80, laureth-4, laureth-23, POE(15) glycerol monolaurate, and mixtures thereof.

7. The topical delivery foam composition of claim 1 , wherein said surfactant is present in an amount of from about 0.1% to about 10% w/w based on the total weight of the composition.

8. The topical delivery foam composition of claim 7 , wherein said surfactant is present in an amount of from about 0.1% to about 6% w/w based on the total weight of the composition.

9. The topical delivery foam composition of claim 1 , wherein said pH adjusting agent is a buffer.

10. The topical delivery foam composition of claim 9 , wherein said buffer is selected from the group consisting of citrate/citric acid, acetate/acetic acid, phosphate/phosphoric acid, formate/formic acid, propionate/propionic acid, lactate/lactic acid, carbonate/carbonic acid and ammonium/ammonia buffer.

11. The topical delivery foam composition of claim 1 , wherein said aqueous quick-breaking foaming agent contains about 0% w/w of an emollient based on the total weight of the composition.

12. The topical delivery foam composition of claim 1 , wherein said composition further comprises xanthan gum.

13. A topical delivery foam composition in a pressurized container, said composition comprising:

benzoyl peroxide and clindamycin or a salt or ester thereof;

an aqueous quick-breaking foaming agent comprising:

a) water,

b) a surfactant, and

c) a pH adjusting agent present in an amount sufficient to adjust the pH of the composition to between about 4.0 to about 6.5, wherein the aqueous quick-breaking foaming agent does not contain a C 1 -C 6 alcohol; and

an aerosol propellant selected from the group consisting of a hydrocarbon, a chlorofluorocarbon, dimethyl ether, hydrofluorocarbons and a mixture thereof,

wherein said composition is a quick-breaking foam after release from said container.

14. The topical delivery foam composition of claim 13 , wherein said surfactant is selected from the group consisting of a block copolymer, fatty acid ethoxylates, fatty alcohol ethoxylates, polysorbates and glycerol ester ethoxylates.

15. The topical delivery foam composition of claim 13 , wherein said surfactant is selected from the group consisting of polysorbate 20, polysorbate 60, polysorbate 80, laureth-4, laureth-23, POE(15) glycerol monolaurate, and mixtures thereof.

16. The topical delivery foam composition of claim 13 , wherein said surfactant is present in an amount of from about 0.1% to about 10% w/w based on the total weight of the composition.

17. The topical delivery foam composition of claim 16 , wherein said surfactant is present in an amount of from about 0.1% to about 6% w/w based on the total weight of the composition.

18. The topical delivery foam composition of claim 13 , wherein said pH adjusting agent is selected from the group consisting of a base and a buffer.

19. The topical delivery foam composition of claim 18 , wherein said pH adjusting agent is a buffer.

20. The topical delivery foam composition of claim 19 , wherein said buffer is selected from the group consisting of citrate/citric acid, acetate/acetic acid, phosphate/phosphoric acid, formate/formic acid, propionate/propionic acid, lactate/lactic acid, carbonate/carbonic acid and ammonium/ammonia buffer.

21. The topical delivery foam composition of claim 20 , wherein said buffer is citrate/citric acid.

22. The topical delivery foam composition of claim 13 , wherein said aqueous quick-breaking foaming agent contains about 0% w/w of an emollient based on the total weight of the composition.

23. The topical delivery foam composition of claim 13 , wherein said composition further comprises xanthan gum.

24. The topical delivery foam composition of claim 1 , wherein said aerosol propellant is a hydrocarbon propellant.

25. The topical delivery foam composition of claim 13 , wherein said aerosol propellant is a hydrocarbon propellant.

26. The topical delivery foam composition of claim 1 , wherein the water is present in an amount of about 80% to about 95% w/w based on the total weight of the composition.

27. The topical delivery foam composition of claim 13 , wherein the water is present in an amount of about 80% to about 95% w/w based on the total weight of the composition.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 30, 2013
From: STIEFEL RESEARCH AUSTRALIA PTY LTD
To: STIEFEL WEST COAST, LLC
Reel/Frame 030511/0963 →